Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Inventory Average (2016 - 2025)

Historic Inventory Average for Bristol Myers Squibb (BMYMP) over the last 16 years, with Q4 2025 value amounting to $2.7 billion.

  • Bristol Myers Squibb's Inventory Average fell 748.85% to $2.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 billion, marking a year-over-year decrease of 748.85%. This contributed to the annual value of $2.6 billion for FY2025, which is 53.65% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Inventory Average stood at $2.7 billion, which was down 748.85% from $2.7 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Inventory Average ranged from a high of $3.2 billion in Q3 2024 and a low of $2.0 billion during Q1 2021
  • Moreover, its 5-year median value for Inventory Average was $2.5 billion (2023), whereas its average is $2.5 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Inventory Average tumbled by 4351.24% in 2021, and later surged by 3352.08% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Inventory Average (Quarter) stood at $2.1 billion in 2021, then increased by 3.64% to $2.2 billion in 2022, then grew by 15.52% to $2.5 billion in 2023, then grew by 15.52% to $2.9 billion in 2024, then dropped by 7.49% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q4 2025, $2.7 billion for Q3 2025, and $2.7 billion during Q2 2025.